ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 073,98
0,57%
Dow Jones
41 920,37
1,04%
DAX
23 154,57
0,94%
Brent Oil
70,755
-0,01%
Bitcoin
84 544,13
2,41%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Ocular Therapeutix Inc (OCUL) Cours

Ocular Therapeutix Inc

Ocular Therapeutix Inc (OCUL)

NASDAQ
7,915
0,195
( 2,53% )
Mis à jour : 20:37:20
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
7,915
Prix Achat
7,91
Prix Vente
7,92
Volume échangé
1 238 994
7,53 Fourchette du Jour 7,9489
4,06 Plage de 52 semaines 11,775
Cap du marché
1,244B
Clôture Veille
7,72
Ouverture
7,71
Dernière Transaction
100
@
7.9133
(average)
Dernière heure de transaction
20:37:23
Volume financier
US$ 9 652 802
VWAP
7,7908
Volume moyen (3 m)
1 124 794
Actions en circulation
157 217 427
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-15,40
Bénéfice par action (BPA)
-0,51
Chiffre d'affairess
58,44M
Bénéfice net
-80,74M

À propos de Ocular Therapeutix Inc

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitation... Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.ocutx.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Ocular Therapeutix Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker OCUL. Le dernier cours de clôture d'Ocular Therapeutix était de US$7,72. Au cours de la dernière année, les actions de Ocular Therapeutix ont été négociées dans une fourchette de prix de US$ 4,06 à US$ 11,775.

Ocular Therapeutix compte actuellement 157 217 427 actions en circulation. La capitalisation boursière d'Ocular Therapeutix est de US$1,21 milliard. Ocular Therapeutix a un ratio cours/bénéfice (ratio PE) de -15.40.

OCUL Dernières nouvelles

Plus de nouvelles

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
03 Mars 2025
OCUL (2,53%)

Form 8-K - Current report
Edgar (US Regulatory)
03 Mars 2025
OCUL (2,53%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 Février 2025
OCUL (2,53%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 Février 2025
OCUL (2,53%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
27 Février 2025
OCUL (2,53%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
24 Février 2025
OCUL (2,53%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
24 Février 2025
OCUL (2,53%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.4656.241610738267.458.927.2618750078.14569782CS
40.6659.17241379317.258.925.7915211027.27989291CS
12-0.585-6.882352941188.59.2155.7911247947.66477551CS
26-1.085-12.0555555556911.7755.7911338778.79799667CS
52-1.545-16.33192389019.4611.7754.0615293407.43794421CS
1562.75553.39147286825.1611.7751.99512366336.11267961CS
2603.70588.00475059384.2124.31.99511270228.04639329CS

OCUL - Frequently Asked Questions (FAQ)

What is the current Ocular Therapeutix share price?
The current share price of Ocular Therapeutix is US$ 7,915
How many Ocular Therapeutix shares are in issue?
Ocular Therapeutix has 157 217 427 shares in issue
What is the market cap of Ocular Therapeutix?
The market capitalisation of Ocular Therapeutix is USD 1,21B
What is the 1 year trading range for Ocular Therapeutix share price?
Ocular Therapeutix has traded in the range of US$ 4,06 to US$ 11,775 during the past year
What is the PE ratio of Ocular Therapeutix?
The price to earnings ratio of Ocular Therapeutix is -15,4
What is the cash to sales ratio of Ocular Therapeutix?
The cash to sales ratio of Ocular Therapeutix is 21,28
What is the reporting currency for Ocular Therapeutix?
Ocular Therapeutix reports financial results in USD
What is the latest annual turnover for Ocular Therapeutix?
The latest annual turnover of Ocular Therapeutix is USD 58,44M
What is the latest annual profit for Ocular Therapeutix?
The latest annual profit of Ocular Therapeutix is USD -80,74M
What is the registered address of Ocular Therapeutix?
The registered address for Ocular Therapeutix is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Ocular Therapeutix website address?
The website address for Ocular Therapeutix is www.ocutx.com
Which industry sector does Ocular Therapeutix operate in?
Ocular Therapeutix operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ANTEAirNet Technology Inc
US$ 1,5602
(91,81%)
104,2M
SCNXScienture Holdings Inc
US$ 2,35
(57,72%)
20,58M
VTVTvTv Therapeutics Inc
US$ 22,75
(53,20%)
483,83k
MGRMMonogram Technologies Inc
US$ 3,5087
(50,59%)
33,31M
RGCRegencell Bioscience Holdings Ltd
US$ 18,96
(50,24%)
2,62M
BONBon Natural Life Ltd
US$ 0,59
(-59,03%)
20,65M
CTORCitius Oncology Inc
US$ 0,57
(-22,34%)
283,89k
STBXStarBox Group Holdings Ltd
US$ 0,209
(-21,63%)
1,47M
HMRHeidmar Maritime Holdings Corporation
US$ 2,7104
(-21,44%)
1,76M
CISOCISO Global Inc
US$ 0,9013
(-20,24%)
19,51M
NVDANVIDIA Corporation
US$ 120,075
(-1,31%)
210,87M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,0901
(-19,48%)
178,94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8,31
(-9,87%)
147,14M
INTCIntel Corporation
US$ 25,695
(6,84%)
134,01M
ANTEAirNet Technology Inc
US$ 1,5602
(91,81%)
104,2M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
OCUL
Ocular Therapeutix
BIT
I09006
Intesa Sanpaolo
BIT
F12963
Vontobel Financial Produ...
BIT
F30600
Vontobel Financial Produ...
USOTC
HKXCY
Hong Kong Exchanges and ... (PK)
LSE
46DR
Perm Mast B 42
BIT
F38321
Vontobel Financial Produ...
BIT
F25654
Vontobel Financial Produ...
BIT
F34698
Vontobel Financial Produ...
BIT
UC7XF9
Unicredit Bank
BIT
UC8ALD
Unicredit Bank
BIT
F39206
Vontobel Financial Produ...
COIN
SUTERUSD
Suterusu
BIT
P1SXI8
BNP Paribas Issuance
BIT
F34665
Vontobel Financial Produ...
TSX
QUE.SB.D
Province of Quebec
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces